$RGEN
REPLIGEN CORP

2024 Q4 Form 10-Q Financial Statement

#000095017024127846 Filed on November 18, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $154.9M
YoY Change 9.69%
Cost Of Revenue $77.38M
YoY Change -26.04%
Gross Profit $77.49M
YoY Change 111.96%
Gross Profit Margin 50.03%
Selling, General & Admin $75.61M
YoY Change 36.32%
% of Gross Profit 97.58%
Research & Development $9.710M
YoY Change -8.2%
% of Gross Profit 12.53%
Depreciation & Amortization $17.66M
YoY Change -10.37%
% of Gross Profit 22.79%
Operating Expenses $85.32M
YoY Change 29.19%
Operating Profit -$7.832M
YoY Change -262.9%
Interest Expense $3.579M
YoY Change 1230.48%
% of Operating Profit
Other Income/Expense, Net $6.683M
YoY Change -2.14%
Pretax Income -$1.149M
YoY Change -109.87%
Income Tax -$500.0K
% Of Pretax Income
Net Earnings -$654.0K
YoY Change -103.6%
Net Earnings / Revenue -0.42%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 56.03M 56.01M
Diluted Shares Outstanding 56.01K

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $784.0M
YoY Change 24.28%
Cash & Equivalents $784.0M
Short-Term Investments
Other Short-Term Assets $36.12M
YoY Change 19.98%
Inventory $182.5M
Prepaid Expenses
Receivables $129.0M
Other Receivables $0.00
Total Short-Term Assets $1.132B
YoY Change 15.65%
LONG-TERM ASSETS
Property, Plant & Equipment $202.6M
YoY Change 0.48%
Goodwill $987.6M
YoY Change 13.62%
Intangibles $380.8M
YoY Change 10.77%
Long-Term Investments
YoY Change
Other Assets $748.0K
YoY Change -48.2%
Total Long-Term Assets $1.699B
YoY Change 10.64%
TOTAL ASSETS
Total Short-Term Assets $1.132B
Total Long-Term Assets $1.699B
Total Assets $2.831B
YoY Change 12.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $21.36M
YoY Change 12.64%
Accrued Expenses $60.90M
YoY Change 43.15%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $0.00
YoY Change -100.0%
Total Short-Term Liabilities $108.4M
YoY Change -70.18%
LONG-TERM LIABILITIES
Long-Term Debt $521.6M
YoY Change
Other Long-Term Liabilities $11.61M
YoY Change 205.58%
Total Long-Term Liabilities $705.6M
YoY Change 334.99%
TOTAL LIABILITIES
Total Short-Term Liabilities $108.4M
Total Long-Term Liabilities $705.6M
Total Liabilities $814.0M
YoY Change 54.87%
SHAREHOLDERS EQUITY
Retained Earnings $441.2M
YoY Change -4.98%
Common Stock $1.610B
YoY Change 2.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.017B
YoY Change
Total Liabilities & Shareholders Equity $2.831B
YoY Change 12.59%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$654.0K
YoY Change -103.6%
Depreciation, Depletion And Amortization $17.66M
YoY Change -10.37%
Cash From Operating Activities $49.32M
YoY Change 25.5%
INVESTING ACTIVITIES
Capital Expenditures $7.138M
YoY Change -21.56%
Acquisitions
YoY Change
Other Investing Activities $1.279M
YoY Change 326.33%
Cash From Investing Activities -$5.859M
YoY Change -33.42%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -69.60M
YoY Change 8600.5%
NET CHANGE
Cash From Operating Activities 49.32M
Cash From Investing Activities -5.859M
Cash From Financing Activities -69.60M
Net Change In Cash -26.14M
YoY Change -188.02%
FREE CASH FLOW
Cash From Operating Activities $49.32M
Capital Expenditures $7.138M
Free Cash Flow $42.18M
YoY Change 39.68%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000730272
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-14656
dei Entity Registrant Name
EntityRegistrantName
REPLIGEN CORP
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
04-2729386
dei Entity Address Address Line1
EntityAddressAddressLine1
41 Seyon Street, Bldg. 1, Suite 100
dei Entity Address City Or Town
EntityAddressCityOrTown
Waltham
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02453
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
250-0111
dei Security12b Title
Security12bTitle
Common Stock
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q4 us-gaap Inventory Net
InventoryNet
202321000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1277000
CY2023Q4 us-gaap Assets
Assets
2831185000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
21357000
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-14656
dei Entity Registrant Name
EntityRegistrantName
REPLIGEN CORP
dei Entity Address City Or Town
EntityAddressCityOrTown
Waltham
dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02453
dei City Area Code
CityAreaCode
781
dei Local Phone Number
LocalPhoneNumber
250-0111
dei Security12b Title
Security12bTitle
Common Stock
dei Trading Symbol
TradingSymbol
RGEN
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Security12b Title
Security12bTitle
Common Stock
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
dei Entity Small Business
EntitySmallBusiness
false
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56026725
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
751323000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1961000
CY2024Q3 us-gaap Goodwill
Goodwill
987620000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
748000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1719839000
CY2024Q3 us-gaap Assets
Assets
2830644000
CY2023Q4 us-gaap Assets
Assets
2831185000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
21357000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19563000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12171000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5631000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
13936000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
12983000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60902000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
164942000
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
510143000
CY2024Q3 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
33686000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
705592000
CY2024Q3 us-gaap Liabilities
Liabilities
813958000
CY2023Q4 us-gaap Liabilities
Liabilities
866340000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56026725
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55766078
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
56026725
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
783964000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
751323000
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1961000
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2122000
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
129026000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
124161000
CY2024Q3 us-gaap Inventory Net
InventoryNet
182465000
CY2023Q4 us-gaap Inventory Net
InventoryNet
202321000
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
36115000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33541000
CY2024Q3 us-gaap Assets Current
AssetsCurrent
1131570000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1111346000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
202583000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
207440000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
380754000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
406957000
CY2024Q3 us-gaap Goodwill
Goodwill
987620000
CY2023Q4 us-gaap Goodwill
Goodwill
987120000
CY2024Q3 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
101000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1530000
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
127268000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
115515000
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
748000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1277000
CY2024Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
1699074000
CY2024Q3 us-gaap Assets
Assets
2830644000
CY2023Q4 us-gaap Assets
Assets
2831185000
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
21357000
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
12171000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5631000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
13936000
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
108366000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
164942000
CY2024Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
521607000
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
510143000
CY2024Q3 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
33686000
CY2023Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
39324000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
138693000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
126578000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
14070000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5631000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
13936000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
12983000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60902000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57313000
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
69452000
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
510143000
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
705592000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
701398000
CY2024Q3 us-gaap Liabilities
Liabilities
813958000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56026725
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56026725
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55766078
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55766078
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1609526000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-34623000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-37808000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
441223000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
432868000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2016686000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2830644000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2831185000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
154871000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
141192000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
466892000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
465741000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
77383000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
104634000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
231088000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
265786000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9710000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10577000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
13936000
CY2024Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
69452000
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
108366000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
164942000
CY2024Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
521607000
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
510143000
CY2024Q3 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
33686000
CY2023Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
39324000
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
138693000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
126578000
CY2024Q3 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
0
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
14070000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11606000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11283000
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
705592000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
701398000
CY2024Q3 us-gaap Liabilities
Liabilities
813958000
CY2023Q4 us-gaap Liabilities
Liabilities
866340000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56026725
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56026725
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55766078
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55766078
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
560000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
558000
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1609526000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1569227000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-34623000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-37808000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
441223000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
432868000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2016686000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1964845000
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11606000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11283000
CY2024Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
705592000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
701398000
CY2024Q3 us-gaap Liabilities
Liabilities
813958000
CY2023Q4 us-gaap Liabilities
Liabilities
866340000
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56026725
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55766078
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55766078
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
560000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
558000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1569227000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-34623000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-37808000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
441223000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
432868000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2016686000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2830644000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2831185000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
154871000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
465741000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
77383000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
104634000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
231088000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
265786000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9710000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10577000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31523000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32437000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
75610000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
55582000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
202894000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
160954000
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55766078
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
560000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
558000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1569227000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-34623000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-37808000
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
441223000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
432868000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2016686000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1964845000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2830644000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2831185000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
154871000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
141192000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
466892000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
465741000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
77383000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
104634000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
231088000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
265786000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9710000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10577000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31523000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32437000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
75610000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
55582000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
202894000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
160954000
CY2024Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2023Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-34292000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
162703000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
136501000
us-gaap Costs And Expenses
CostsAndExpenses
465505000
us-gaap Costs And Expenses
CostsAndExpenses
427911000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7832000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4691000
us-gaap Operating Income Loss
OperatingIncomeLoss
37830000
CY2024Q3 us-gaap Investment Income Net
InvestmentIncomeNet
9130000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
6662000
us-gaap Investment Income Net
InvestmentIncomeNet
27534000
us-gaap Investment Income Net
InvestmentIncomeNet
18112000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5122000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
408000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
15269000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1227000
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2830644000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2831185000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
154871000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
466892000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
465741000
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
77383000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
104634000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
231088000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
265786000
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
9710000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10577000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31523000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32437000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
75610000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
55582000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
202894000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
160954000
CY2024Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2023Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-34292000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-31266000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
162703000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
136501000
us-gaap Costs And Expenses
CostsAndExpenses
465505000
us-gaap Costs And Expenses
CostsAndExpenses
427911000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7832000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4691000
us-gaap Operating Income Loss
OperatingIncomeLoss
1387000
us-gaap Operating Income Loss
OperatingIncomeLoss
37830000
CY2024Q3 us-gaap Investment Income Net
InvestmentIncomeNet
9130000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
6662000
us-gaap Investment Income Net
InvestmentIncomeNet
27534000
us-gaap Investment Income Net
InvestmentIncomeNet
18112000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5122000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
408000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
15269000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1227000
CY2024Q3 rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
429000
CY2023Q3 rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
459000
rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
1432000
rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
1373000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3104000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
895000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-647000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1500000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6683000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6690000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
31523000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32437000
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
75610000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
55582000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
202894000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
160954000
CY2024Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
CY2023Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-34292000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-31266000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
162703000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
136501000
us-gaap Costs And Expenses
CostsAndExpenses
465505000
us-gaap Costs And Expenses
CostsAndExpenses
427911000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7832000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4691000
us-gaap Operating Income Loss
OperatingIncomeLoss
37830000
CY2024Q3 us-gaap Investment Income Net
InvestmentIncomeNet
9130000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
6662000
us-gaap Investment Income Net
InvestmentIncomeNet
18112000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5122000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
408000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
15269000
CY2024Q3 rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
429000
CY2023Q3 rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
459000
rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
1432000
rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
1373000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3104000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
895000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-647000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1500000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6683000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6690000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10186000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1149000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11381000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11573000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
54842000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-495000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5542000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3218000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2796000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2024Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-31266000
CY2024Q3 us-gaap Costs And Expenses
CostsAndExpenses
162703000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
136501000
us-gaap Costs And Expenses
CostsAndExpenses
465505000
us-gaap Costs And Expenses
CostsAndExpenses
427911000
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-7832000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4691000
us-gaap Operating Income Loss
OperatingIncomeLoss
37830000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
6662000
us-gaap Investment Income Net
InvestmentIncomeNet
27534000
us-gaap Investment Income Net
InvestmentIncomeNet
18112000
CY2024Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
5122000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
408000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
15269000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1227000
CY2024Q3 rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
429000
CY2023Q3 rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
459000
rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
1432000
rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
1373000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3104000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
895000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-647000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1500000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6683000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6690000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10186000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17012000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1149000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11381000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11573000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
54842000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-495000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5542000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3218000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2796000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.3
CY2024Q3 rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
429000
CY2023Q3 rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
459000
rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
1432000
rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
1373000
CY2024Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
3104000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
895000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-647000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1500000
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6683000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6690000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10186000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17012000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1149000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11381000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11573000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
54842000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-495000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5542000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3218000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2796000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56012
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55766
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55896
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55688
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56012
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56940
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9822000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5880000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3185000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8972000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9168000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11043000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11540000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
10186000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17012000
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-1149000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11381000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11573000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
54842000
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-495000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5542000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3218000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2796000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56012
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55766
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55896
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55688
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56012
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56940
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56315
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56933
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9822000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5880000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3185000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8972000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9168000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11043000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11540000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
43074000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1984438000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2024Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-7000
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
577000
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
545000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23055000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56012
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55766
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55896
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55688
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56012
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56940
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56315
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56933
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9822000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5880000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3185000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8972000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9168000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11043000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11540000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
43074000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1984438000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2024Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-7000
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
577000
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
545000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23055000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
9822000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2016686000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1956859000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-10000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
294000
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1038000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6373000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-5880000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1973743000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1964845000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2016686000
us-gaap Net Income Loss
NetIncomeLoss
52046000
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-13000
rgen Stock Issued During Period Value Contingent Consideration Earnout Payment
StockIssuedDuringPeriodValueContingentConsiderationEarnoutPayment
7229000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56012
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55766
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55896
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55688
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56012
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56940
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56933
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2024Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
9822000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5880000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
3185000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8972000
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
9168000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11043000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11540000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
43074000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1984438000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2024Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-7000
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
577000
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
545000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23055000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
9822000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2016686000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1956859000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-10000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
294000
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1038000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6373000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-5880000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1973743000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1964845000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-114000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2366000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9404000
rgen Stock Issued During Period Value Contingent Consideration Earnout Payment
StockIssuedDuringPeriodValueContingentConsiderationEarnoutPayment
5742000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
41711000
CY2024Q3 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
3185000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2016686000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1910700000
us-gaap Net Income Loss
NetIncomeLoss
52046000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
43074000
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
1984438000
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2024Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-7000
CY2024Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
577000
CY2024Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
545000
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
23055000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
9822000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2016686000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1956859000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-10000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
294000
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1038000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-5880000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1973743000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1964845000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-114000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2366000
us-gaap Net Income Loss
NetIncomeLoss
52046000
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-13000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
356000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
12178000
rgen Stock Issued During Period Value Contingent Consideration Earnout Payment
StockIssuedDuringPeriodValueContingentConsiderationEarnoutPayment
7229000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19110000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-8972000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1973743000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
51306000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
51295000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
11628000
us-gaap Share Based Compensation
ShareBasedCompensation
19110000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4163000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9268000
rgen Noncash Interest Income
NoncashInterestIncome
0
rgen Noncash Interest Income
NoncashInterestIncome
2023000
rgen Increasedecrease In Operating Lease Right Of Use Asset
IncreasedecreaseInOperatingLeaseRightOfUseAsset
-12749000
rgen Increasedecrease In Operating Lease Right Of Use Asset
IncreasedecreaseInOperatingLeaseRightOfUseAsset
-10203000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1275000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4631000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8315000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-20131000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-25979000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2609000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12749000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-484000
CY2024Q2 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
9822000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2016686000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1956859000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
CY2023Q3 us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-10000
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
294000
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
1038000
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
6373000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-5880000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1973743000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1964845000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-114000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2366000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
9404000
rgen Stock Issued During Period Value Contingent Consideration Earnout Payment
StockIssuedDuringPeriodValueContingentConsiderationEarnoutPayment
5742000
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2016686000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1910700000
us-gaap Net Income Loss
NetIncomeLoss
52046000
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-13000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
356000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
12178000
rgen Stock Issued During Period Value Contingent Consideration Earnout Payment
StockIssuedDuringPeriodValueContingentConsiderationEarnoutPayment
7229000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19110000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-8972000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1973743000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Net Income Loss
NetIncomeLoss
52046000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
51306000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
51295000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
11628000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1373000
us-gaap Share Based Compensation
ShareBasedCompensation
41711000
us-gaap Share Based Compensation
ShareBasedCompensation
19110000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4163000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9268000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-31266000
rgen Noncash Interest Income
NoncashInterestIncome
0
rgen Noncash Interest Income
NoncashInterestIncome
2023000
rgen Increasedecrease In Operating Lease Right Of Use Asset
IncreasedecreaseInOperatingLeaseRightOfUseAsset
-12749000
rgen Increasedecrease In Operating Lease Right Of Use Asset
IncreasedecreaseInOperatingLeaseRightOfUseAsset
-10203000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-107000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1275000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4631000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8315000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-20131000
us-gaap Stock Issued During Period Value Conversion Of Units
StockIssuedDuringPeriodValueConversionOfUnits
-13000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
356000
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
12178000
rgen Stock Issued During Period Value Contingent Consideration Earnout Payment
StockIssuedDuringPeriodValueContingentConsiderationEarnoutPayment
7229000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-8972000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Net Income Loss
NetIncomeLoss
52046000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
51306000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
51295000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
11628000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1373000
us-gaap Share Based Compensation
ShareBasedCompensation
41711000
us-gaap Share Based Compensation
ShareBasedCompensation
19110000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4163000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9268000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-31266000
rgen Noncash Interest Income
NoncashInterestIncome
0
rgen Noncash Interest Income
NoncashInterestIncome
2023000
rgen Increasedecrease In Operating Lease Right Of Use Asset
IncreasedecreaseInOperatingLeaseRightOfUseAsset
-12749000
rgen Increasedecrease In Operating Lease Right Of Use Asset
IncreasedecreaseInOperatingLeaseRightOfUseAsset
-10203000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-107000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1275000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4631000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8315000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-20131000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-25979000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2609000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12749000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-484000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
707000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1780000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5360000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12514000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5849000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-141000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
136218000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2774000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2736000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20137000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25135000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1290000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
21000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21621000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
46630000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2366000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
356000
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
19110000
CY2022Q4 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-8972000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1973743000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Net Income Loss
NetIncomeLoss
52046000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
51306000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
51295000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
11628000
us-gaap Share Based Compensation
ShareBasedCompensation
19110000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-4163000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9268000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
0
rgen Noncash Interest Income
NoncashInterestIncome
0
rgen Noncash Interest Income
NoncashInterestIncome
2023000
rgen Increasedecrease In Operating Lease Right Of Use Asset
IncreasedecreaseInOperatingLeaseRightOfUseAsset
-12749000
rgen Increasedecrease In Operating Lease Right Of Use Asset
IncreasedecreaseInOperatingLeaseRightOfUseAsset
-10203000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-107000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1275000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
4631000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8315000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-20131000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-25979000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2609000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12749000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-484000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
707000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1780000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8619000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5360000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12514000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5849000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7676000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-141000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
79000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
136218000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
84853000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
27843000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
0
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
102323000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2774000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2736000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20137000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25135000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1290000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
21000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21621000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
356000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
2609000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12749000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
-484000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
707000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12514000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5849000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
136218000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
84853000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
27843000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
0
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
102323000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2774000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2736000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
20137000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25135000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1290000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
21000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21621000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
46630000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2366000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
356000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9403000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12178000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
69939000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
33000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7375000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7298000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-13000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-84351000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19166000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2395000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4996000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
107321000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
751323000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
523458000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
630779000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
24087000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1129000
rgen Fair Value Of Shares Of Common Stock Issued For Contingent Consideration Earnouts
FairValueOfSharesOfCommonStockIssuedForContingentConsiderationEarnouts
5742000
rgen Fair Value Of Shares Of Common Stock Issued For Contingent Consideration Earnouts
FairValueOfSharesOfCommonStockIssuedForContingentConsiderationEarnouts
7229000
CY2023Q1 rgen Cancelled Purchase Orders In Exchange For Payment
CancelledPurchaseOrdersInExchangeForPayment
17300000
CY2023Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
0
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2122000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1365000
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
707000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
1780000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
5360000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12514000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-5849000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-141000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
84853000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
0
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
102323000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2774000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2736000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1290000
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
21000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21621000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
46630000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
2366000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
356000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9403000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12178000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
69939000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
33000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7375000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7298000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-13000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-84351000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19166000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2395000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4996000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32641000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
107321000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
751323000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
523458000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
783964000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
630779000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
24087000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1129000
rgen Fair Value Of Shares Of Common Stock Issued For Contingent Consideration Earnouts
FairValueOfSharesOfCommonStockIssuedForContingentConsiderationEarnouts
5742000
rgen Fair Value Of Shares Of Common Stock Issued For Contingent Consideration Earnouts
FairValueOfSharesOfCommonStockIssuedForContingentConsiderationEarnouts
7229000
CY2023Q1 rgen Cancelled Purchase Orders In Exchange For Payment
CancelledPurchaseOrdersInExchangeForPayment
17300000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
751323000
CY2023Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
0
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2122000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1365000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
124161000
CY2023Q4 us-gaap Inventory Net
InventoryNet
202321000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
9403000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12178000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
69939000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
33000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7298000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-13000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-84351000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19166000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2395000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4996000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32641000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
107321000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
751323000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
783964000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
630779000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
24087000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1129000
rgen Fair Value Of Shares Of Common Stock Issued For Contingent Consideration Earnouts
FairValueOfSharesOfCommonStockIssuedForContingentConsiderationEarnouts
5742000
rgen Fair Value Of Shares Of Common Stock Issued For Contingent Consideration Earnouts
FairValueOfSharesOfCommonStockIssuedForContingentConsiderationEarnouts
7229000
CY2023Q1 rgen Cancelled Purchase Orders In Exchange For Payment
CancelledPurchaseOrdersInExchangeForPayment
17300000
CY2023Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
0
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2122000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1365000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
124161000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33541000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1111346000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1530000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
115515000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1277000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1719839000
CY2023Q4 us-gaap Assets
Assets
2831185000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19563000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5631000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
12983000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57313000
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
69452000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
164942000
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
510143000
CY2023Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
39324000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
126578000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
14070000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11283000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
701398000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12178000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
69939000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
33000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7375000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7298000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
0
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-13000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-84351000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19166000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2395000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4996000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
32641000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
107321000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
751323000
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
783964000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
630779000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
24087000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1129000
rgen Fair Value Of Shares Of Common Stock Issued For Contingent Consideration Earnouts
FairValueOfSharesOfCommonStockIssuedForContingentConsiderationEarnouts
5742000
rgen Fair Value Of Shares Of Common Stock Issued For Contingent Consideration Earnouts
FairValueOfSharesOfCommonStockIssuedForContingentConsiderationEarnouts
7229000
CY2023Q1 rgen Cancelled Purchase Orders In Exchange For Payment
CancelledPurchaseOrdersInExchangeForPayment
17300000
CY2023Q4 us-gaap Held To Maturity Securities Current
HeldToMaturitySecuritiesCurrent
0
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
2122000
CY2022Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1365000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
124161000
CY2023Q4 us-gaap Inventory Net
InventoryNet
202321000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33541000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1111346000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
207440000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
406957000
CY2023Q4 us-gaap Goodwill
Goodwill
987120000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1530000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
115515000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1277000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1719839000
CY2023Q4 us-gaap Assets
Assets
2831185000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19563000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5631000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
12983000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57313000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
164942000
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
510143000
CY2023Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
39324000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
126578000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
124161000
CY2023Q4 us-gaap Inventory Net
InventoryNet
202321000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33541000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1111346000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
207440000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
406957000
CY2023Q4 us-gaap Goodwill
Goodwill
987120000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1530000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
115515000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1277000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1719839000
CY2023Q4 us-gaap Assets
Assets
2831185000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19563000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5631000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
12983000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57313000
CY2023Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
69452000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
164942000
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
510143000
CY2023Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
39324000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
126578000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
14070000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11283000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
701398000
CY2023Q4 us-gaap Liabilities
Liabilities
866340000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55766078
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55766078
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55557698
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55557698
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1569227000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-37808000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
432868000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
141192000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
465741000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
104634000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
265786000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10577000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32437000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
33541000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
1111346000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
207440000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
406957000
CY2023Q4 us-gaap Goodwill
Goodwill
987120000
CY2023Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1530000
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
115515000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
1277000
CY2023Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1719839000
CY2023Q4 us-gaap Assets
Assets
2831185000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
19563000
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
5631000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
12983000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57313000
CY2023Q4 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
510143000
CY2023Q4 us-gaap Deferred Tax And Other Liabilities Noncurrent
DeferredTaxAndOtherLiabilitiesNoncurrent
39324000
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
126578000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
14070000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11283000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
701398000
CY2023Q4 us-gaap Liabilities
Liabilities
866340000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55766078
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55766078
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55557698
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55557698
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
558000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1569227000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-37808000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
432868000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1964845000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2831185000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
141192000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
465741000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
104634000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
265786000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10577000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32437000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
55582000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
160954000
CY2023Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-34292000
CY2023Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
14070000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
11283000
CY2023Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
701398000
CY2023Q4 us-gaap Liabilities
Liabilities
866340000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55766078
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55766078
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55557698
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55557698
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
432868000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1964845000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2831185000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
141192000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
465741000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
104634000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
265786000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10577000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32437000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
55582000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
160954000
CY2023Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-34292000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-31266000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
136501000
us-gaap Costs And Expenses
CostsAndExpenses
427911000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4691000
us-gaap Operating Income Loss
OperatingIncomeLoss
37830000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
6662000
us-gaap Investment Income Net
InvestmentIncomeNet
18112000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
408000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1227000
CY2023Q3 rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
459000
rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
1373000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
895000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1500000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6690000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17012000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11381000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
54842000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5542000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2796000
CY2023Q4 us-gaap Liabilities
Liabilities
866340000
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55766078
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55766078
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55557698
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55557698
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
558000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1569227000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-37808000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
432868000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1964845000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2831185000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
141192000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
465741000
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
104634000
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
265786000
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
10577000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
32437000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
55582000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
160954000
CY2023Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-34292000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-31266000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
136501000
us-gaap Costs And Expenses
CostsAndExpenses
427911000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4691000
us-gaap Operating Income Loss
OperatingIncomeLoss
37830000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
408000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1227000
CY2023Q3 rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
459000
rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
1373000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
895000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1500000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6690000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17012000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5542000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2796000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
55582000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
160954000
CY2023Q3 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-34292000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
136501000
us-gaap Costs And Expenses
CostsAndExpenses
427911000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4691000
us-gaap Operating Income Loss
OperatingIncomeLoss
37830000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
6662000
CY2023Q3 rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
459000
rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
1373000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
895000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1500000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6690000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17012000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11381000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
54842000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5542000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2796000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55766
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55688
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56940
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56933
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5880000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8972000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11043000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1956859000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5880000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1973743000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8972000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1973743000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
51295000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1373000
us-gaap Share Based Compensation
ShareBasedCompensation
19110000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9268000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-31266000
rgen Noncash Interest Income
NoncashInterestIncome
2023000
rgen Increasedecrease In Operating Lease Right Of Use Asset
IncreasedecreaseInOperatingLeaseRightOfUseAsset
-10203000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1275000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-31266000
CY2023Q3 us-gaap Costs And Expenses
CostsAndExpenses
136501000
us-gaap Costs And Expenses
CostsAndExpenses
427911000
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
4691000
us-gaap Operating Income Loss
OperatingIncomeLoss
37830000
CY2023Q3 us-gaap Investment Income Net
InvestmentIncomeNet
6662000
us-gaap Investment Income Net
InvestmentIncomeNet
18112000
CY2023Q3 us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
408000
us-gaap Interest Expense Nonoperating
InterestExpenseNonoperating
1227000
CY2023Q3 rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
459000
rgen Amortization Of Debt Issuance Cost
AmortizationOfDebtIssuanceCost
1373000
CY2023Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
895000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
1500000
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
6690000
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
17012000
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
11381000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
54842000
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-5542000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2796000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55766
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56940
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5880000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8972000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11043000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
43074000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1956859000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5880000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1973743000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1910700000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
51295000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1373000
us-gaap Share Based Compensation
ShareBasedCompensation
19110000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-9268000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-31266000
rgen Noncash Interest Income
NoncashInterestIncome
2023000
rgen Increasedecrease In Operating Lease Right Of Use Asset
IncreasedecreaseInOperatingLeaseRightOfUseAsset
-10203000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1275000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8315000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-25979000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12749000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56940
us-gaap Net Income Loss
NetIncomeLoss
52046000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8972000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11043000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
43074000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1956859000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5880000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1973743000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1910700000
us-gaap Net Income Loss
NetIncomeLoss
52046000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8972000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1973743000
us-gaap Net Income Loss
NetIncomeLoss
52046000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
51295000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1373000
us-gaap Share Based Compensation
ShareBasedCompensation
19110000
us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
-31266000
rgen Noncash Interest Income
NoncashInterestIncome
2023000
rgen Increasedecrease In Operating Lease Right Of Use Asset
IncreasedecreaseInOperatingLeaseRightOfUseAsset
-10203000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1275000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8315000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-25979000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12749000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
707000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8619000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12514000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7676000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
79000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
27843000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
102323000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2736000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25135000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-21000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
46630000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
356000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12178000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7298000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-13000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19166000
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55766
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5880000
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8972000
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
11043000
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
43074000
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
1956859000
CY2023Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-5880000
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
1973743000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1910700000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
51295000
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1373000
us-gaap Share Based Compensation
ShareBasedCompensation
19110000
rgen Noncash Interest Income
NoncashInterestIncome
2023000
rgen Increasedecrease In Operating Lease Right Of Use Asset
IncreasedecreaseInOperatingLeaseRightOfUseAsset
-10203000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1275000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8315000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-25979000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12749000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
707000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8619000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12514000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7676000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
79000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
84853000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
27843000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25135000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-21000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
46630000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
356000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12178000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
33000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7298000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-13000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19166000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4996000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
630779000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1129000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-8315000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-25979000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12749000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
707000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8619000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12514000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7676000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
79000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
84853000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
27843000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
102323000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2736000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25135000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-21000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
46630000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12178000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
33000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7298000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-13000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19166000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4996000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
107321000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
523458000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
630779000
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
707000
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-8619000
us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-12514000
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-7676000
us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
79000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
84853000
us-gaap Payments To Acquire Businesses Net Of Cash Acquired
PaymentsToAcquireBusinessesNetOfCashAcquired
27843000
us-gaap Proceeds From Sale And Maturity Of Held To Maturity Securities
ProceedsFromSaleAndMaturityOfHeldToMaturitySecurities
102323000
us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
2736000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
25135000
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
0
us-gaap Payments For Proceeds From Other Investing Activities
PaymentsForProceedsFromOtherInvestingActivities
-21000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
356000
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
12178000
us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
33000
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
7298000
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
-13000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19166000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4996000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
523458000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
630779000
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4996000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
107321000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
523458000
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
630779000
us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
1129000
CY2024Q3 rgen Short Term Contingent Consideration
ShortTermContingentConsideration
13936000
CY2023Q4 rgen Short Term Contingent Consideration
ShortTermContingentConsideration
12983000
CY2024Q3 us-gaap Restructuring Costs
RestructuringCosts
2900000
us-gaap Restructuring Costs
RestructuringCosts
5300000
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
24000000
us-gaap Restructuring Costs
RestructuringCosts
24000000
CY2024Q3 rgen Short Term Contingent Consideration
ShortTermContingentConsideration
13936000
CY2023Q4 rgen Short Term Contingent Consideration
ShortTermContingentConsideration
12983000
CY2023Q4 rgen Long Term Contingent Consideration
LongTermContingentConsideration
14070000
CY2024Q3 us-gaap Restructuring Costs
RestructuringCosts
2900000
us-gaap Restructuring Costs
RestructuringCosts
5300000
CY2024Q3 rgen Short Term Contingent Consideration
ShortTermContingentConsideration
13936000
CY2023Q4 rgen Short Term Contingent Consideration
ShortTermContingentConsideration
12983000
CY2023Q4 rgen Long Term Contingent Consideration
LongTermContingentConsideration
14070000
CY2024Q3 us-gaap Restructuring Costs
RestructuringCosts
2900000
us-gaap Restructuring Costs
RestructuringCosts
5300000
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
24000000
us-gaap Restructuring Costs
RestructuringCosts
24000000
CY2024Q3 us-gaap Restructuring Costs
RestructuringCosts
2918000
us-gaap Restructuring Costs
RestructuringCosts
5311000
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
24012000
us-gaap Restructuring Costs
RestructuringCosts
5311000
us-gaap Payments For Restructuring
PaymentsForRestructuring
5745000
rgen Restructuring Reserve Gain Loss On Non Cash Items
RestructuringReserveGainLossOnNonCashItems
166000
CY2024Q3 us-gaap Restructuring Reserve
RestructuringReserve
196000
CY2024Q3 rgen Short Term Contingent Consideration
ShortTermContingentConsideration
13936000
CY2023Q4 rgen Short Term Contingent Consideration
ShortTermContingentConsideration
12983000
CY2023Q4 rgen Long Term Contingent Consideration
LongTermContingentConsideration
14070000
CY2024Q3 us-gaap Restructuring Costs
RestructuringCosts
2900000
us-gaap Restructuring Costs
RestructuringCosts
5300000
us-gaap Restructuring Costs
RestructuringCosts
24000000
CY2024Q3 us-gaap Restructuring Costs
RestructuringCosts
2918000
us-gaap Restructuring Costs
RestructuringCosts
5311000
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
24012000
us-gaap Restructuring Costs
RestructuringCosts
24012000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
464000
us-gaap Restructuring Costs
RestructuringCosts
5311000
us-gaap Payments For Restructuring
PaymentsForRestructuring
5745000
rgen Restructuring Reserve Gain Loss On Non Cash Items
RestructuringReserveGainLossOnNonCashItems
166000
CY2024Q3 us-gaap Restructuring Reserve
RestructuringReserve
196000
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
24000000
us-gaap Restructuring Costs
RestructuringCosts
24000000
CY2024Q3 us-gaap Restructuring Costs
RestructuringCosts
2918000
us-gaap Restructuring Costs
RestructuringCosts
5311000
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
24012000
us-gaap Restructuring Costs
RestructuringCosts
24012000
us-gaap Restructuring Costs
RestructuringCosts
5311000
us-gaap Payments For Restructuring
PaymentsForRestructuring
5745000
rgen Restructuring Reserve Gain Loss On Non Cash Items
RestructuringReserveGainLossOnNonCashItems
166000
CY2024Q3 us-gaap Restructuring Reserve
RestructuringReserve
196000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
154871000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
141192000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
466892000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
465741000
CY2024Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
129026000
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
124161000
CY2024Q3 us-gaap Deferred Revenue
DeferredRevenue
16884000
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
17536000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
15365000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
18751000
CY2024Q3 us-gaap Restructuring Costs
RestructuringCosts
2918000
CY2023Q3 us-gaap Restructuring Costs
RestructuringCosts
24012000
us-gaap Restructuring Costs
RestructuringCosts
24012000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
464000
us-gaap Restructuring Costs
RestructuringCosts
5311000
us-gaap Payments For Restructuring
PaymentsForRestructuring
5745000
rgen Restructuring Reserve Gain Loss On Non Cash Items
RestructuringReserveGainLossOnNonCashItems
166000
CY2024Q3 us-gaap Restructuring Reserve
RestructuringReserve
196000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
154871000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
141192000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
466892000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
465741000
CY2024Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
129026000
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
124161000
CY2024Q3 us-gaap Deferred Revenue
DeferredRevenue
16884000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
18751000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
154871000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
141192000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
466892000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
465741000
CY2024Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
129026000
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
124161000
CY2024Q3 us-gaap Deferred Revenue
DeferredRevenue
16884000
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
17536000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
15365000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
18751000
CY2023Q4 us-gaap Goodwill
Goodwill
987120000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-556000
CY2024Q3 us-gaap Goodwill
Goodwill
987620000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
539445000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
159391000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
380054000
CY2024Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
154871000
CY2023Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
141192000
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
465741000
CY2024Q3 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
129026000
CY2023Q4 us-gaap Contract With Customer Receivable After Allowance For Credit Loss
ContractWithCustomerReceivableAfterAllowanceForCreditLoss
124161000
CY2024Q3 us-gaap Deferred Revenue
DeferredRevenue
16884000
CY2023Q4 us-gaap Deferred Revenue
DeferredRevenue
17536000
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
15365000
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
18751000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-556000
CY2024Q3 us-gaap Goodwill
Goodwill
987620000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
539445000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
159391000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
380054000
CY2024Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
540145000
CY2023Q4 us-gaap Goodwill
Goodwill
987120000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-556000
CY2024Q3 us-gaap Goodwill
Goodwill
987620000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
539445000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
159391000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
380054000
CY2024Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
540145000
CY2024Q3 rgen Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
159391000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
380754000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
539396000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
133139000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
406257000
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
540096000
CY2023Q4 rgen Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
133139000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
406957000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8600000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7600000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26000000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22800000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
8620000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
34354000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
34000000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
33965000
us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
-556000
CY2024Q3 us-gaap Goodwill
Goodwill
987620000
us-gaap Impairment Of Intangible Assets Excluding Goodwill
ImpairmentOfIntangibleAssetsExcludingGoodwill
0
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
539445000
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
159391000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
380054000
CY2024Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
540145000
CY2024Q3 rgen Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
159391000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
380754000
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
539396000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
133139000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
406257000
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
540096000
CY2023Q4 rgen Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
133139000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
406957000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26000000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
22800000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
8620000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
34354000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
34000000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
33965000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
33863000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
235252000
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
106843000
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6794000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4492000
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
68828000
CY2024Q3 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2024Q3 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
540145000
CY2024Q3 rgen Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
159391000
CY2024Q3 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
380754000
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
406257000
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2023Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
540096000
CY2023Q4 rgen Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
133139000
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
406957000
CY2024Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
8600000
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7600000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26000000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
8620000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
34354000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
34000000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
33965000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
33863000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
235252000
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
380054000
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
106843000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
123598000
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6794000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4492000
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
68828000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
74231000
CY2024Q3 us-gaap Inventory Net
InventoryNet
182465000
CY2023Q4 us-gaap Inventory Net
InventoryNet
202321000
CY2024Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1000000
CY2024Q3 rgen Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
159391000
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
133139000
CY2023Q4 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P15Y
CY2023Q3 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
7600000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
26000000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
8620000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
34354000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
34000000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
33965000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
33863000
CY2024Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
235252000
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
106843000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
123598000
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6794000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4492000
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
68828000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
74231000
CY2024Q3 us-gaap Inventory Net
InventoryNet
182465000
CY2023Q4 us-gaap Inventory Net
InventoryNet
202321000
CY2024Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1000000
CY2024Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1000000
CY2024Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
200000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
200000
CY2024Q3 us-gaap Land
Land
893000
CY2024Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
142506000
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
126663000
CY2024Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
120029000
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
114606000
CY2024Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
10035000
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
9077000
CY2024Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
40790000
CY2023Q4 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
35528000
CY2024Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
40241000
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
47086000
CY2024Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
488000
CY2023Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
544000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
355707000
CY2024Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
106843000
CY2024Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
6794000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4492000
CY2024Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
68828000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
74231000
CY2024Q3 us-gaap Inventory Net
InventoryNet
182465000
CY2023Q4 us-gaap Inventory Net
InventoryNet
202321000
CY2024Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
200000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
200000
CY2024Q3 us-gaap Land
Land
893000
CY2024Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
725000
CY2024Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
142506000
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
126663000
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
114606000
CY2024Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
10035000
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
9077000
CY2024Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
40790000
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
47086000
CY2024Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
488000
CY2023Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
544000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
355707000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
336163000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
153124000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
128723000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
202583000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
207440000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28104000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16660000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
74231000
CY2024Q3 us-gaap Inventory Net
InventoryNet
182465000
CY2023Q4 us-gaap Inventory Net
InventoryNet
202321000
CY2024Q1 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1000000
CY2024Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1000000
CY2024Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
200000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
200000
CY2024Q3 us-gaap Land
Land
893000
CY2023Q4 us-gaap Land
Land
992000
CY2024Q3 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
725000
CY2023Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
1667000
CY2024Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
142506000
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
126663000
CY2024Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
120029000
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
114606000
CY2024Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
10035000
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
9077000
CY2024Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
40790000
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
47086000
CY2024Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
488000
CY2023Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
544000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
355707000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
336163000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
153124000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
128723000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
202583000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
207440000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28104000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16660000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
16446000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
17067000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
148000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16204000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16772000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60902000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57313000
CY2024Q2 us-gaap Assets Of Disposal Group Including Discontinued Operation Current
AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent
1000000
CY2024Q3 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
200000
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
200000
CY2024Q3 us-gaap Land
Land
893000
CY2024Q3 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
142506000
CY2023Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
126663000
CY2024Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
120029000
CY2023Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
114606000
CY2024Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
10035000
CY2023Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
9077000
CY2024Q3 us-gaap Capitalized Computer Software Gross
CapitalizedComputerSoftwareGross
40790000
CY2024Q3 us-gaap Construction In Progress Gross
ConstructionInProgressGross
40241000
CY2023Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
47086000
CY2024Q3 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
488000
CY2023Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
544000
CY2024Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
355707000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
336163000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
153124000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
128723000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
202583000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
207440000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28104000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16660000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
16446000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
17067000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
148000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6814000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16204000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16772000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60902000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57313000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
136
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
22400000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
336163000
CY2024Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
153124000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
128723000
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
202583000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
207440000
CY2024Q3 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
28104000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
16660000
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
16446000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
17067000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
148000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6814000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16204000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60902000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57313000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
136
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
22400000
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
23055000
us-gaap Share Based Compensation
ShareBasedCompensation
19110000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
649130
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
85.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
77014
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
175.6
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
43725
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
54.11
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
32027
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
195.78
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
650392
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
93.31
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
398851
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
76.47
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
644688
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
92.66
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
16446000
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
17067000
CY2024Q3 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
148000
CY2023Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6814000
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16204000
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
16772000
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
60902000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
57313000
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
136
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
22400000
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
23055000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
6373000
us-gaap Share Based Compensation
ShareBasedCompensation
41711000
us-gaap Share Based Compensation
ShareBasedCompensation
19110000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
649130
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
85.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
77014
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
175.6
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
43725
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
54.11
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
32027
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
195.78
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
650392
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
93.31
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
398851
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
76.47
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
644688
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
92.66
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y3M21D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
43311000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3400000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
89.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
85.7
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
474320
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
155.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
221584
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
180.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
137072
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
144.8
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
82452
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
136
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
22400000
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
23055000
CY2023Q3 us-gaap Share Based Compensation
ShareBasedCompensation
6373000
us-gaap Share Based Compensation
ShareBasedCompensation
41711000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
649130
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
85.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
77014
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
175.6
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
43725
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
54.11
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
32027
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
195.78
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
650392
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
93.31
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
398851
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
76.47
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
644688
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
92.66
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y3M21D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
43311000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3400000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
89.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
85.7
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
474320
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
155.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
221584
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
180.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
137072
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
144.8
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
82452
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
190.45
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
164.04
rgen Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber
415171
CY2024Q3 rgen Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue
162.37
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
62100000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M25D
CY2024Q3 us-gaap Share Based Compensation
ShareBasedCompensation
23055000
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
649130
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
85.97
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
77014
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
175.6
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
43725
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
54.11
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
32027
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
195.78
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
650392
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
93.31
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
398851
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
76.47
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
644688
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
92.66
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y3M21D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
43311000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3400000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
89.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
85.7
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
474320
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
155.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
221584
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
180.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
137072
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
144.8
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
82452
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
190.45
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
476380
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
164.04
rgen Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber
415171
CY2024Q3 rgen Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue
162.37
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
62100000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M25D
CY2024Q3 rgen Sharebased Compensation Arrangement By Sharebased Payment Award Options And Equity Instruments Other Than Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedNumberOfShares
2300804
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P5Y3M21D
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
43311000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
4700000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
89.09
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
85.7
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
474320
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
155.59
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
221584
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
180.02
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
137072
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
144.8
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
82452
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
190.45
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
476380
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
164.04
rgen Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber
415171
CY2024Q3 rgen Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue
162.37
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
62100000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M25D
CY2024Q3 rgen Sharebased Compensation Arrangement By Sharebased Payment Award Options And Equity Instruments Other Than Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedNumberOfShares
2300804
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-500000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3200000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.43
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.278
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.487
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.051
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56012
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55766
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55896
CY2024Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
0
CY2023Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
439
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
190.45
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
476380
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
164.04
rgen Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestNumber
415171
CY2024Q3 rgen Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Expected To Vest Outstanding Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndExpectedToVestOutstandingWeightedAverageGrantDateFairValue
162.37
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
62100000
us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P2Y9M25D
CY2024Q3 rgen Sharebased Compensation Arrangement By Sharebased Payment Award Options And Equity Instruments Other Than Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedNumberOfShares
2300804
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-500000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3200000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.43
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.278
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.487
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.051
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
56012
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55766
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55896
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55688
CY2024Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
0
CY2023Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
439
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
419
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
469
CY2024Q3 rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
0
CY2023Q3 rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
735
rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
0
rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
776
CY2024Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1174
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
419
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1245
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56012
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56940
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-500000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3200000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.43
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.278
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.487
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.051
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55766
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55896
CY2024Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
0
CY2023Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
439
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
419
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
469
CY2024Q3 rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
0
CY2023Q3 rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
735
rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
0
rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
776
CY2024Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1174
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
419
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1245
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56012
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56940
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56315
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56933
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
491206
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
404989
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-500000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
3200000
CY2024Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.43
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.278
CY2023Q3 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.487
us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.051
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-654000
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
16923000
us-gaap Net Income Loss
NetIncomeLoss
8355000
us-gaap Net Income Loss
NetIncomeLoss
52046000
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55766
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
55896
CY2024Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
0
CY2023Q3 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
439
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
419
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
469
CY2024Q3 rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
0
CY2023Q3 rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
735
rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
0
rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
776
CY2024Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1174
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
419
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1245
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56012
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56940
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56315
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56933
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
491206
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
404989
us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
469
CY2024Q3 rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
0
CY2023Q3 rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
735
rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
0
rgen Dilutive Securities Effect On Basic Earnings Per Share Convertible Senior Notes
DilutiveSecuritiesEffectOnBasicEarningsPerShareConvertibleSeniorNotes
776
CY2024Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0
CY2023Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1174
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
419
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
1245
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56012
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56940
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56315
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56933
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
491206
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
404989
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
301404
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
328179
CY2024Q3 rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
0
rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
0
CY2023Q3 rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
735150
rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
776339
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56315
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
56933
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.3
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.15
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.93
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.3
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.15
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.91
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
491206
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
404989
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
301404
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
328179
CY2024Q3 rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
0
rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
0
CY2023Q3 rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
735150
rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
776339
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
CY2023Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 rgen Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
301404
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
328179
CY2024Q3 rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
0
rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
0
CY2023Q3 rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
735150
rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
776339
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
CY2023Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 rgen Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
301404
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
328179
CY2024Q3 rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
0
rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
0
CY2023Q3 rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
735150
rgen Dilutive Effect On Shares Of Conversion Premium
DilutiveEffectOnSharesOfConversionPremium
776339
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2024Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
CY2023Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 rgen Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023Q3 us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
us-gaap Concentration Risk Percentage1
ConcentrationRiskPercentage1
1
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 rgen Rule10 B51 Arr Modified Flag
Rule10B51ArrModifiedFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
0000950170-24-127846-index-headers.html Edgar Link pending
0000950170-24-127846-index.html Edgar Link pending
0000950170-24-127846.txt Edgar Link pending
0000950170-24-127846-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgen-20240930.htm Edgar Link pending
rgen-20240930.xsd Edgar Link pending
rgen-20240930_htm.xml Edgar Link completed
0000950170-24-127846-index-headers.html Edgar Link pending
0000950170-24-127846-index.html Edgar Link pending
0000950170-24-127846.txt Edgar Link pending
0000950170-24-127846-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
rgen-ex31_1.htm Edgar Link pending
rgen-ex31_2.htm Edgar Link pending
rgen-ex32_1.htm Edgar Link pending
Show.js Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R76.htm Edgar Link pending
R77.htm Edgar Link pending
R78.htm Edgar Link pending
R79.htm Edgar Link pending
R8.htm Edgar Link pending
R80.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgen-20240930.htm Edgar Link pending
rgen-20240930.xsd Edgar Link pending
rgen-ex31_1.htm Edgar Link pending
rgen-ex31_2.htm Edgar Link pending
rgen-ex32_1.htm Edgar Link pending
Show.js Edgar Link pending
rgen-20240930_htm.xml Edgar Link completed
FilingSummary.xml Edgar Link unprocessable